Ossiam cut its stake in Bristol-Myers Squibb ( NYSE:BMY – Get Rating ) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,391 shares of the biopharmaceutical company's stock after selling 778 shares during the quarter. Ossiam's holdings in Bristol-Myers Squibb were worth $5,280,000 at the end of the most recent quarter. A number of other institutional investors and hedge funds also recently modified their holdings of BMY.

https://www.dailypolitical.com/2023/06/05/ossiam-sells-778-shares-of-bristol-myers-squibb-nysebmy.html

#dailypolitical